IRTC Stock Analysis: Buy, Sell, or Hold?
IRTC - iRhythm Technologies, Inc
$161.30
5.57 (3.58%)
▲
5d:
+3.03%
30d:
-7.94%
90d:
-13.88%
BUY
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Feb 19, 2026
14d
Get Alerted When IRTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IRTC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: IRTC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IRTC is currently trading at $161.30, which is considered slightly low relative to its 30-day fair value range of $156.72 to $179.84.
Technical Outlook: Technically, IRTC is in a downtrend. Immediate support is located at $148.14, while resistance sits at $166.99. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: IRTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (22th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $221.27 (+37.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IRTC is in a downtrend. Immediate support is located at $148.14, while resistance sits at $166.99. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: IRTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (22th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $221.27 (+37.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$156.72 -
$179.84
Company Quality Score
55/100
(HOLD)
Options IV Signal
22th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 22th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 37.2% below Wall St target ($221.27)
Fair Price Analysis
30-Day Fair Range
$156.72 -
$179.84
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$11.88
(7.4%)
Support & Resistance Levels
Support Level
$148.14
Resistance Level
$166.99
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-590.84
Wall Street Target
$221.27
(+37.2%)
Revenue Growth (YoY)
30.7%
Profit Margin
-7.3%
Last updated: February 04, 2026 9:34 AM ET
Data refreshes hourly during market hours. Next update: 10:34 AM
Data refreshes hourly during market hours. Next update: 10:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Daniel G Wilson
SELL
5000 shares
2025-09-03
Sumi Shrishrimal
SELL
653 shares
2025-08-22
Abhijit Y Talwalkar
SELL
5312 shares
2025-08-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 67 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 57 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
Advanced IRTC Option Strategies
Professional options setups generated by AI based on today's IRTC price and gamma walls.
